Institute of Pathology, Forensic Medicine and Cytology, Clinical Hospital Center Split, Spinčićeva 1, 21 000 Split, Croatia.
Pathol Oncol Res. 2013 Jan;19(1):71-7. doi: 10.1007/s12253-012-9559-z. Epub 2012 Aug 28.
Due to the worldwide implementation of the mammographic screening program early breast cancer (T1a,b) has become more prevalent form of breast cancer. Although T1a,b breast cancers are generally associated with excellent prognosis, some of them, particularly those with lymph node involvement, has unfavourable outcome. Searching for additional prognostic factors, we investigated DNA content of 163 T1a,b cancers measured by DNA flow cytometry, and correlated it with regional lymph node status. T1a,b cancers were divided into four ploidy classes based on their DNA index (DI): hypodiploid (DI < 0.95), diploid (DI 0.95-1.05), low-hyperploid (DI 1.06-1.3), and high-hyperploid (DI > 1.3). Diploid T1a,b cancers were associated with negative lymph node status (p = 0.003). Among aneuploid cancers only low-hyperploid tumors were associated with positive lymph node status (p = 0.03). The histopathological features of low-hyperploid group of T1a,b cancers did not differ from the other three ploidy groups of cancers, except for lower S-phase fraction of tumor cells in low-hyperploid group compared to high-hyperploid group (p = 0.01). Our data showed that near-diploid hyperploid T1a,b cancers are associated with higher risk of lymph node involvement despite similar clinicopathological features shared with other ploidy classes of T1a,b tumors.
由于全球范围内实施了乳房 X 光筛查计划,早期乳腺癌(T1a、b)已成为更为普遍的乳腺癌形式。尽管 T1a、b 乳腺癌通常与良好的预后相关,但其中一些,特别是那些伴有淋巴结受累的患者,预后并不理想。为了寻找其他预后因素,我们通过 DNA 流式细胞术检测了 163 例 T1a、b 乳腺癌的 DNA 含量,并将其与区域淋巴结状态相关联。根据 DNA 指数(DI),T1a、b 乳腺癌被分为四个倍体类群:低倍体(DI<0.95)、二倍体(DI 0.95-1.05)、低-高倍体(DI 1.06-1.3)和高-高倍体(DI>1.3)。二倍体 T1a、b 乳腺癌与阴性淋巴结状态相关(p=0.003)。在非整倍体肿瘤中,只有低-高倍体肿瘤与阳性淋巴结状态相关(p=0.03)。低-高倍体 T1a、b 乳腺癌的组织病理学特征与其他三个倍体组的肿瘤没有区别,除了低-高倍体组肿瘤细胞的 S 期分数低于高-高倍体组(p=0.01)。我们的数据表明,近二倍体高倍体 T1a、b 乳腺癌尽管与其他 T1a、b 肿瘤的倍体类群具有相似的临床病理特征,但与更高的淋巴结受累风险相关。